Dier Mardi bought MDGL
December 2, 2025 · Form 4 insider transaction
Dier Mardi bought 4,173 shares of Madrigal Pharmaceuticals, Inc. at $251.63 per share, a transaction worth $1.05M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,173
Price
$251.63
Total value
$1.05M
InsiderDier Mardi
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 2, 2025
Filing dateDecember 3, 2025
Shares owned after14,613
OwnershipDirect
10b5-1 planNo
AmendedNo